Symposium - European Medical Journal

Continue

Symposiums

Dermatology
6 Mins
2 Mar 2022

Revolution in Photoprotection: How to Recommend and Adapt Photoprotection According to Skin Phototype and Dermatoses

The solar spectrum is composed of various wavelengths of electromagnetic radiation that can penetrate the skin to different levels: the longer…
EMJ Oncology 10 [Supplement 4] 2022 Feature Image
Oncology
7 Mins
24 Feb 2022

Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer

Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…
EMJ
Hematology
9 Mins
21 Feb 2022

The Search for Sustained Durability in Higher-Risk Myelodysplastic Syndrome: New Treatment Pathways in Sight

Higher-risk MDS is a collective term based on the Revised International Prognostic Scoring System (IPSS-R) that encompasses…
Oncology
11 Mins
18 Feb 2022

New Developments, Data, and Guideline Updates: Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism Associated with Cancer – Interviews with Key Opinion Leaders

CAT is a serious complication that can affect up to 6% of patients with cancer, and is associated with a 2–5-fold increased risk of…
Dermatology
5 Mins
3 Feb 2022

Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from the EADV 2021

The latest research on autoimmune skin disease has studied the efficacy and safety characterisation of guselkumab (GUS), a human monoclonal…
Dermatology
10 Mins
3 Feb 2022

Diving Deep: Harnessing the Potential of the IL-23 Pathway

Strober began by summarising his opinion on the key characteristics of anti-IL-23 therapies that support their efficacy for inducing…
EMJ Oncology 10 [Supplement 2] 2022 feature
Oncology
14 Mins
3 Feb 2022

Optimising Cholangiocarcinoma Diagnosis and Treatment Focusing on Precision Medicine

This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…
Hematology
12 Mins
31 Jan 2022

Updates on Isatuximab in Relapsed/Refractory and Newly Diagnosed Multiple Myeloma

In the past decade, therapies that are more effective and less toxic have transformed the treatment landscape for patients with MM…
We’ve noticed you’re accessing
from North/South America.